Clinical Trials Browser

Phase 2 × INDUSTRY × 90Y-octreotide, DOTA-Tyr(3)- × Clear all

NCT00006370 2013-05-01

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Lung Neoplasms, Breast Neoplasms, Male, Small Cell Lung Carcinoma